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IN Northern Ireland, during 1978-79, there was a major outbreak of rubella. A
similar outbreak affected the rest of the United Kingdom and other countries
throughout theworld. ",2 We have investigated the outcome ofpregnancies ofwomen
who were diagnosed virologically as having rubella in the first four months of
pregnancy during 1978-79. In addition, all infants born in 1978-79 and suspected of
having intrauterine rubella infection, or who were conceived during 1979 and born
during 1980, were tested and those who had rubella specific immunoglobulin M
(IgM), were followed up.
MATERIALS AND METHODS
Where possible acute and convalescent sera were obtained from pregnant women
after contact with rubella. Rubella haemagglutination-inhibition (HI) antibody was
titrated in sera after removal of inhibitors with dextran sulphate- CaC12'3Trypsin
modified human 0 erythrocytes were used.4 Antibody titres were expressed as
reciprocals. Rubella specific IgM was measured in sera by the indirect fluorescent
antibody test on rubella infected VERO cells.5 Sera were absorbed with monkey liver
powder, heat aggregated human immunoglobulin to eliminate non-specific staining
due to possible rheumatoid factor in serum6 and protein A Sepharose (Pharmacia)
to decrease interfering IgG.7
All infants, born in 1978, 1979, and the first 9 months of 1980, who were clinically
suspected of having congenital rubella had their sera fractionated by ultra centri-
fugation on a sucrose density gradient8 and fractions containing rubella specific IgM
were detected by the indirect fluorescent antibody test as above.
In pregnant women after contact with rubella, acute rubella infection was
diagnosed if the acute sera had no detectable antibody ( < 10) and a four-fold or
greater rise of antibody developed in convalescent sera. In women who were bled
later than one week after contact and who had high ( 9 160) but not rising titres of
rubella antibody, rubella specific IgM was measured and, if detected, indicated
rubella virus infection within the previous two months.
The minimum immune titre of rubella HI antibody9 in this laboratory is 20 which
is equivalent to at least 15 International Units per ml. of rubella antibody.'0 Rubella
HI antibody at a titre of 20 or higher, indicates that the pregnant woman is immune
either in a routine screening test, or within one week after contact with rubella.
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Before the outbreak:- Between June 1973 and October 1975, sera from 1000
pregnant women attending antenatal clinics in hospital or general practice through-
out Northern Ireland were tested for rubella HI antibody; 81.2 per cent had a titre
of 20 or greater, and were regarded as immune.
The outbreak:- The number of pregnant women who either had a rash or who
were in contact with suspected rubella and whose blood was sent to the laboratory is
shown in the Figure. The peak incidence was June and July during 1978, and May
during 1979. Although the numberofrequests dropped during the winter of1978-79,
they did not fall below pre-outbreak levels. The commonest history of contact with
rubella was with a young child in the same household. There were 1229 more
requests for rubella serology in pregnant women in 1979 compared with 1978. Many
other blood samples from pregnant women who did not have rubella or contact were














per month from pregnant
women in Northern Ireland
who had a rash or contact*
with suspected rubella.
*Date of contact is shown and not
date of request.
Rubella in Pregnant Women
Sixty-seven women in 1978 were diagnosed by the laboratory as having had
rubella. On follow-up, two were found not to be pregnant, and five could not be
traced. Of the 60 remaining women, 31 had greater than four-fold rising titres of
rubella antibody while 29 had raised but static rubella antibody titres with rubella
specific IgM present in their sera. Thirty-two (53 per cent) women were recorded as
having had a rash. In 1979, 108 women were diagnosed by the laboratory as having
had rubella. On follow-up, 11 were found not to be pregnant, and seven could not
be traced. Ofthe 90 women remaining, 36 had greater than four-fold rising titres of
rubella antibody, while 54 had raised but static rubella antibody titres with rubella
66specific IgM present in their sera. Thirty-eight women (42 per cent) were recorded as
having had a rash. Of the 150 women with proven rubella, the ages ranged from 16
to 40 years with a mean of 27.1 years. Geographically, 100 of these women were
located in urban areas: Belfast (33), South Antrim (32), Craigavon (17), North
Down (16) and Londonderry City (2).
In 1979, a 29-year-old woman had clinical rubella during the first month of
gestation of her third pregnancy. Rubella specific IgM was present in her serum
taken three weeks later. A female infant was born with hepatosplenomegaly and
multiple congenital abnormalities which included patent ductus arteriosus, deafness,
cataract, microphthalmia, and retinopathy. Rubella specific IgM was present in her
serum. The mother had received Cendehill rubella vaccine eight years previously.
OUTCOME OF PREGNANCY
Table 1 shows the outcome ofpregnancy. Ofthe 150 pregnant women with proven
rubella, 69 (46 per cent) had a therapeutic abortion. Of the 81 mothers who
continued their pregnancy there were 69 (85 per cent) normal liveborn infants, three
apparently normal stillbirths, and nine (11 per cent) infants with congenital
abnormalities. These infantswere followed-up, andTable2details theabnormalities.
All nine mothers had a history ofa rash during the pregnancy. Six ofthe nine infants
were female, and three weighed less than 2500 grams. In two infants rubella specific
IgM was not detected, but the interval between their date of birth and the date of
testing was 20 and 23 months, respectively. Both babies had rubella HI antibody
titres of 20, while antibody titres of toxoplasma, herpes simplex virus, and cytome-
galovirus were not significant. Since rubella HI antibody had persisted longer than
six months after birth, they are included.
TABLE 1
Outcome ofPregnancy in Women with Laboratory Proven Rubella
Number of Outcome ofpregnancy
Year women with Induced Normal Normal Abnormal
proven rubella abortion livebirths stillbirths infants
1978 67' 27 27 2 4
(60)
1979 1082 42 42 1 5
(90)
Total 175 69 69 3 9
(150)
In 1978 and 1979, 2140 and 3369 (total 5509) women were tested.
I In 1978 5 women could not be traced, and 2 women were found not to be pregnant.
2 In 1979 7 women could not be traced, and 11 women were found not to be pregnant.
( ) = Number of pregnant women with proven rubella traced.
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Abnormal Infants born to Mothers with Laboratory Proven Rubella
MOTHER INFANT
Gestation Birth Sex Clinicalfeatures
(weeks) weight
10 3365 F Deafness
8 3175 M Systolic murmur, hepatosplenomegaly, purpura.
8 2180 M Deafness, systolic murmur.
8 1620 M Fallots tetralogy, hepatosplenomegaly, osteitis.
14 3310 F2 Generalised erythematous rash; Click right hip.
4 2400 F Deafness, cataract, microphthalmia, and
retinopathy, patent ductus arteriosus,
hepatosplenomegaly.
7 3340 F2 Large interior fontanelle, bronchiolitis.
7 3005 F Chest infections.
6 3062 F Right cataract.
I All 9 mothers had a history of rubella in pregnancy.
2 Rubella specific IgM negative but rubella HI antibody present.
Abnormal infants with rubella specific IgM born to mothers not tested during
pregnancy
A further nine infants with rubella specific IgM born to mothers not tested during
pregnancy were identified from sera sent to the Regional Virus Laboratory because
congenital rubella was suspected in the infant (Table 3). Of these mothers, three had
no history of rubella during pregnancy, and of the other six mothers, five had had a
rash during pregnancy. The remaining mother had been in contact with rubella and
had received human immunoglobulin. The abnormalities in the nine infants are
detailed in Table 3. Five of the 9 infants were female and 4 weighed less than 2500
grams. Congenital rubella infants
A total of 91 infants were tested for rubella specific IgM either because they had
been born to women with proven rubella during pregnancy, or because congenital
rubella was suspected in the neonatal period. Eighteen infants had rubella specific
IgM in their sera. Two of these infants born in the first five months of 1978 were
excluded from the study since they were infected in utero before the rubella
outbreak, and 2 affected infants who only had rubella HI antibody, 20 and 23
months after birth, were included. Of the 14 mothers who had a history of clinical
rubella, one mother had a history in the first month of pregnancy, 9 in the second
month, 3 in the third month, and 1 in the fourth month. Of the 18 infants with
congenital rubella infection, at the time of follow-up, 7 had deafness, 7 had had a
skin rash, 7 had congenital heart disease, 5 had hepatosplenomegaly, 4 had
congenital cataract, 2 had osteitis, and one had microcephaly. Two infants presented
only with chest infections and bronchiolitis. One infant with hypospadias and a bifid
scrotum, had Klinefelter's syndrome (47,XXY). His mother had been in contact
with rubella at 8 weeks gestation and had received human immunoglobulin.
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12 R 2860 M Hepatomegaly, purpuric rash, anaemia.
6 R 1644 F Deafness, multiple eye defects, patent ductus
arteriosus, aortic stenosis, purpuric rash, wide
fontanelle, growth retardation (post natal).
8 C* 2380 M Hyposadias, bifid scrotum, Klinefelter's
syndrome.
8 R 3410 M Deafness, jaundice, rash, microcephaly, spastic
quadriplegia, osteitis.
NR NR 2070 F Hepatomegaly, thrombocytopenic purpura.
-- 2920 M Systolic murmur, purpura, thrombocytopenia,
croup.
6 R 2235 F Post natal growth retardation.
12 R 2510 F Deafness, systolic murmur.
NR NR 2722 F Deafness, cataract, and microphthalmia,
delayed development.
NR = not recorded.
* = human immunoglobulin given.
- = no known contact.
TABLE 4
Number and Prevalence Rateper 100,000 Livebirths ofInfants
with Congenital Rubella in Northern Ireland
Number of Number of Congenital Rateper 100,000
Year Livebirths Rubella Infants Livebirths
1977 25,437 1 3.9
1978 26,237 5* 19.1
1979 28,179 11 39.0
1980 28,568 4 14.0
1981 27,297 0
* includes the two patients born 1978 but not included in study because infected before onset ofepidemic.
69Table 4 shows the prevalence rate per 100,000 livebirths in Northern Ireland from
1977 to 1981. Before the outbreak the rate was 3.9 and reached a peak of 39.0 in
1979; in the post-outbreak period the rate fell to 14.0 in 1980, and so far no case of
congenital rubella born in 1981 has been identified.
DISCUSSION
In Northern Ireland, with a population of 1.5 million, all diagnostic virology is
carried out by the Regional Virus Laboratory, and the monitoring ofbirth defects is
undertaken by the Northern Ireland Genetics Service. As both these services are
responsible for the whole ofNorthern Ireland, this facilitated the study ofthe effects
of rubella in pregnancy during the outbreak. The outbreak took place against a
background of 81 per cent of pregnant women being immune. Epidemic rubella
usually appears in late winter and spring, but in the Northern Ireland outbreak the
peaks were in June-July in 1978 and in May 1979. The number ofcases ofcongenital
rubella was greater in 1979 than in 1978, a finding similar to Scotland, whereas in
England and Wales the pattern was reversed, with more cases occurring in 1978 than
in 1979.1, 2 The pregnant women with proven rubella lived in the more densely
populated eastern area with only two occurring in Londonderry in the north-west,
the second largest city in Northern Ireland.
The follow-up of 150 pregnant women with laboratory proven rubella revealed
that 69 (46 per cent) had had a therapeutic abortion; in England and Wales the
figure was 54 per cent." If therapeutic abortion had been unavailable, a further 7 or
8 congenital rubella babies might have been born.
Five problems became apparent during the investigation of the rubella outbreak.
The first problem related to the extensive news media coverage during the epidemic.
The laboratory was swamped with specimens from many pregnant women who did
not have rubella or any contact with rubella, yet were anxious, following the
inaccurate reports of the risk of having a congenital rubella baby. The second
problem concerned the exposure ofpregnant women to rubella. During the outbreak
it was noted that the commonest history of exposure was with young children
suffering from rubella in her own home or elsewhere. However, in the United
Kingdom the policy is to immunise girls only between their 10th and 14th birthdays
which is ineffective in preventing rubella in younger boys and girls. Rubella vaccine
is also strongly recommended for non-pregnant women ofchild-bearing age who are
seronegative but this policy has not been implemented.
The third problem of rubella infection was that some women and their doctors
were unaware of the infection. In 1978 and in 1979, only 53 per cent and 42 per cent
of the rubella infected pregnant women had a rash. Since rubella embryopathy can
occur with sub-clinical rubella infection,'2' 13 laboratory tests are important in
women with a history of contact with rubella but without clinical symptoms. The
fourth problem was that previous rubella immunisation was not a guarantee of
immunity in a pregnant woman as in one of our patients. Rubella vaccine does not
produce 100%7o immunity in those immunised.14 In addition, some of those
immunised may produce only low rubella antibody titres which may disappear later.
The Cendehill rubella vaccine induces a lower seroconversion rate,'4 lower serum
antibody titres and less rubella specific serum and nasopharyngeal IgA than the
70RA27/3 rubella vaccine. Re-infections also are more frequent after Cendehill rubella
vaccine.1'
The fifth problem, despite widespread publicity of the outbreak in both local and
national news media, was that some pregnant women in contact with rubella and
who also developed a rash, did not have laboratory investigations carried out
(Table3). One mother, after contact with rubella, was given human immunoglobulin
which failed toprevent the infection ofthe fetus with rubella virus. Human immuno-
globulin in normal dosage does not prevent rubella infection but may sometimes
prevent the development of symptoms.'6
In the 81 pregnant women with proven rubella who went to term, only nine (11 per
cent) had abnormal babies. However, it is possible that some apparently normal
infants at birth may develop "late onset" disease in infancy.'7 From several
prospective studies, the overall percentage of infants with rubella defects following
rubella in the first 4 months of pregnancy is 14.4 per cent.'8 In our study 14 (78 per
cent) of the 18 mothers with congenital rubella infants, had a history of clinical
rubella during the first four months of pregnancy. A rubella infection which
produces clinical symptoms in the mother is more likely to be associated with rubella
defects in the baby than rubella infection without symptoms.", 13
In our study, rubella infection in the mother during the second month of
pregnancy resulted in 10 out of 14 (71 per cent) congenital rubella infants. This
finding agrees with the increased risk of defects at this gestation found by
Dudgeon.18
Seven of the 18 congenital rubella babies had birth weights below 2500g. Intra-
uterine and extrauterine growth retardation is a feature of congenital rubella
infection.", '9 Among our rubella babies there was a high prevalence of deafness,
skin rashes, hepatosplenomegaly, congenital heart defects and cataracts, whereas,
osteitis, pulmonary infections and microcephaly were much less frequent. Two
infants had chest infections which may represent rubella interstitial pneumonitis.
One baby with Klinefelter's syndome has hypospadias and a bifid scrotum. Hypo-
spadias was previously described in a rubella baby.'9
The fact that 89 per cent of babies born to mothers with proven rubella were
apparently normal at birth raises interesting questions. The virulence ofthe strain of
rubella virus in aparticular epidemic may influence the number offetuses infected in
utero or the HLA antigens of the mother and fetus may determine susceptibility to
infection with rubella virus.20
The prevalence of congenital rubella is difficult to determine because of
incomplete reporting of documented or suspected cases, and because of the
difficulty in diagnosis. A National Congenital Rubella Surveillance Programme for
Great Britain, was established in May 1971.21 Following a peak of 11.9/100,000
livebirths in 1973, there was a gradual decline to 2.9 in 1977. In 1978 and 1979 the
respective prevalence rates were 7.0 and 9.7.22 In Northern Ireland, the prevalence
rates for 1978, 1979, and 1980, were 19.1, 39.0, and 14.0, respectively, with a pre-
and post-epidemic prevalence of 3.9 and 0 in 1977 and 1981. As a result ofthe 1978
rubella epidemic in Chicago, 31 infants with congenital rubella were identified,
giving a prevalence rate of48.9 between July 1978 and June 1979.23 During the same
period in Northern Ireland, the prevalence rate was 32.6.
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Prior to the 1978-79 rubella epidemic in Northern Ireland, 81 per cent ofpregnant
women were immune to rubella. There was more rubella in 1979 than in 1978.
During the epidemic 150 women in the first four months of pregnancy had
laboratory proven rubella and ofthese, 70 (47 per cent) had a recorded rash, 69 (46
per cent) had a therapeutic abortion, and ofthe 81 women remaining, 9 (11 per cent)
had babies with congenital rubella.
A total of eighteen congenital rubella infants were identified; nine were born to
mothers with proven rubella, and nine to the mothers who had no investigations. In
14 of the 18 (78 per cent) mothers, there was a history of clinical rubella. Ten
mothers were infected with rubella in the second month of pregnancy.
One mother, who had received Cendehill rubella vaccine eight years previously,
had clinical rubella during pregnancy and delivered a baby with multiple congenital
abnormalities. Another mother received human immunoglobulin after rubella
contact in pregnancy; her baby had hypospadias, bifid scrotum, and Klinefelter's
syndrome.
The prevalence rate (per 100,000 livebirths) of congenital rubella infants in
Northern Ireland, was 19.1, 39.0, and 14.0, for the years 1978, 1979, and 1980,
compared with 3.9 in 1977. To date no case ofcongenital rubella has been identified
in infants born in 1981.
We wish to thank the following: Mrs. Ruth McDonald for tracing and abstracting hospital records;
Mrs. Dorothy Wyatt and Mr. J.D. Russell, for technical assistance.
REFERENCES
I Smithells RW, Sheppard S, Marshall WC and Milton A. National Congenital Rubella Surveillance
Programme 1971-81. Br Med J 1982; 285: 1363.
2 Anonymous. National Congenital Rubella Surveillance Programme. Br MedJ 1981; 282: 324.
3 Nelson DB, Quirin EP and Inhorn SI. Improved dextran sulphate-calcium chloride method for the
removal of non-specific inhibitors with modifications for non-specific agglutinin removal in the
rubella haemagglutination-inhibition test. AppliedMicrobiology 1972; 24: 264-269.
4 Quirin EP, Nelson DB and Inhorn SI. Use of trypsin-modified human erythocytes in rubella
haemagglutination-inhibition testing. Applied Microbiology 1972; 24: 353-357.
5 Haire M and Hadden DSM. Rapid diagnosis of rubella by demonstrating rubella specific IgM anti-
bodies in serum by indirect immunofluorescence. J MedMicrobiol 1972; 5: 237-242.
6 Shirodaria PV, Fraser KB and Stanford F. Secondary fluorescent staining of virus antigens by
rheumatoid factor and fluorescein-conjugated anti-IgM. Ann Rheum Dis 1973; 32: 53-57.
7 Skaug K and Gaarder PI. An indirect immunofluroescent antibody test for determination of rubella
virus specific IgM antibodies. Elimination of secondary IgM rheumatoid staining after absorption
of serum IgG with staphylococcal protein A. Acta Path Microbiol Scand.. Sect C, 1978; 86: 33-35.
8 Herrmann KL. Rubella Virus in Lennette EH and Schmidt NJ, eds. Diagnostic Proceduresfor Viral
Rickettsial and Chlamydial infections. 5th Edition. Washington: American Public Health
Association Inc, 1979; 725-766.
9 Bradstreet CMP, Kirkwood B, Pattison JR and Tobin JO'H. The derivation of minimum immune
titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service
collaborative survey. Journal Hygiene Cambridge 1978; 81: 383-388.
7210 Kurtz JB, Mortimer PP, Mortimer PR, Morgan-Capner P, Shafi MS and White GBB. Rubella
antibody measured by radial haemolysis. Characteristics and performance of a simple screening
method for use in diagnostic laboratories. Journal Hygiene Cambridge 1980; 84: 213-222.
11 Miller E, Cradock-Watson JE and Pollock TM. Consequences of confirmed maternal rubella at
successive stages of pregnancy. Lancet 1982; ii: 781-784.
12 Sever JL, Hardy JB, Nelson KB and Gilkeson MR. Rubella in the collaborative Perinatal Research
Study II Clinical and Laboratory findings in children through 3 years of age. Amer J Dis Child
1969; 118: 123-132.
13 Peckham CS. Clinical and Serological Assessment of Children Exposed in utero to Confirmed
Maternal Rubella. Br Med J 1974; 1: 259-261.
14 Freestone DS. Rubella: which vaccine? Lancet 1979; ii: 858.
15 Best JM, Harcourt GC, O'Shea S and Banatvala JE. Rubella vaccines. Lancet 1979; ii: 690-691.
16 Anonymous. Studies on the effect of Immunoglobulin on Rubella in Pregnancy. Report ofthe Public
Health Laboratory Service Working Party on Rubella. Br Med J 1970; 2: 497-500.
17 Dudgeon JA. Infective casues of human malformations. Br Med Bull 1976; 32: 77-83.
18 Dudgeon JA. Virus infections in Obstetrics In: Mac Donald RR, ed. ScientificBasis ofObstetricsand
Gynaecology, 2nd Edition. London: Churchill-Livingstone, 1978; 151-179.
19 Hardy JB, Monif GRC and Sever JL. Studies in congenital rubella, Baltimore 1964-65, II Clinical and
virologic. Bull Johns Hopkins Hosp 1966; 118: 97-108.
20 Ishii K, Nakazono N, Sawada H, FukudaK, WakisakaA, Moriuchi J, Nakai Y, KanoTand AizawaM.
Host factors and susceptibility to rubella virus infection: The association of HLA antigens. JMed
Virol 1981; 7: 287-297.
21 Anonymous. National Congenital Rubella Surveillance Programme. Br Med J 1979; 2: 396-397.
22 Smithells RW and Shappard S. Personal Communication, 1982.
23 Lamprecht C, Schauf V, Warren D, Nelson K, Northrop R and Christiansen M. An outbreak of
congenital rubella in Chicago. JAMA 1982; 247: 1129-1133.
73